GlaxoSmithKline and Vitae Sign Hypertension Collaboration
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 62 (Table of Contents)
Published: 5 Aug-2005
DOI: 10.3833/pdr.v2005.i62.637 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Vitae Pharmaceuticals and GlaxoSmithKline entered into research & development agreement to develop and commercialize drugs for treating hypertension and related cardiovascular disorders...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS